lncRNA LEF1-AS1 Acts as a Novel Biomarker and Promotes Hypopharyngeal Squamous Cell Carcinoma Progression and Metastasis by Targeting the miR-221-5p/GJA1 Axis

Dis Markers. 2022 Mar 25:2022:3881310. doi: 10.1155/2022/3881310. eCollection 2022.

Abstract

Hypopharyngeal squamous cell carcinoma (HSCC) is highly malignant and extremely aggressive, making it one of the worst prognoses among all kinds of head and neck squamous cell carcinoma (HNSCC); therefore, gaining insight into molecular mechanisms of HSCC is of profound significance. In the current manuscript, we revealed the elevated expression of long noncoding RNA (lncRNA) LEF1-AS1 in HNSCC which was associated with the poor prognosis by bioinformatic analysis. Moreover, we noticed that LEF1-AS1 dramatically accelerated the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) process in HSCC cell line FaDu. Most importantly, we illustrated that LEF1-AS1 played as a competitive endogenous RNA (ceRNA) via sponging miR-221-5p and thereby positively regulated gap junction protein alpha 1 (GJA1) expression, thus aggravated tumor progression and EMT. In conclusion, for the first time, we demonstrated lncRNA LEF1-AS1 as a novel biomarker for HNSCC and suggested LEF1-AS1/miR-221-5p/GJA1 axis as promising diagnostic and therapeutic target for HSCC treatment.

MeSH terms

  • Biomarkers
  • Cell Proliferation / genetics
  • Connexin 43* / genetics
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Head and Neck Neoplasms* / genetics
  • Humans
  • Lymphoid Enhancer-Binding Factor 1* / genetics
  • MicroRNAs* / genetics
  • Neoplasm Invasiveness / genetics
  • RNA, Long Noncoding* / genetics
  • Squamous Cell Carcinoma of Head and Neck* / genetics

Substances

  • Biomarkers
  • Connexin 43
  • GJA1 protein, human
  • LEF1 protein, human
  • Lymphoid Enhancer-Binding Factor 1
  • MIRN221 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding